Document:

Exhibit 10.1

 

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

 

This SECOND
Amendment to Employment Agreement (this “Amendment”) is made and entered as of this 5th day of
January, 2015, (the “Amendment Effective Date”) by and between InspireMD, Inc., a Delaware corporation
(the “Company”), and Alan W. Milinazzo (the “Executive”) for purposes of amending
that certain Employment Agreement dated as of January 3, 2013, as first amended on April 24, 2013, by and between the Company and
the Executive (the “Agreement”). Terms used in this Amendment with initial capital letters that are not
otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.

 

WHEREAS, Section
7.5 of the Agreement provides that the parties to the Agreement may amend the Agreement in a writing signed by the parties; and

 

WHEREAS, the
parties hereto desire to amend the Agreement in certain respects.

 

NOW THEREFORE,
pursuant to Section 7.5 of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged,
the Company and the Executive agree as follows:

 

1.       A new Section 2.5 is hereby added to the Agreement to read in its entirety as follows.

 

2.5         Temporary
Base Salary Redistribution. Notwithstanding the foregoing, the Executive and the Company agree that for a limited period of
time to be mutually agreed to by the parties, the Executive shall receive 50% of his base salary in cash payments, with the remaining
50% to be paid in an equivalent amount of Restricted Stock, payable and granted in equal installments in accordance with the Company’s
normal payroll practices. The Restricted Stock shall vest immediately and be valued as of the trading day on the date the cash
base salary was previously payable. For the avoidance of any doubt, the parties agree that the definition of Base Amount set forth
in Exhibit A hereto, shall refer only to the full amount of the Executive’s base salary prior to any redistribution or reduction
agreed to hereunder.

 

2.       Except
as expressly amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions
thereof.

 

3.       In
the event of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

* * * * * * * * * *

[Remainder of Page Intentionally Left
Blank

Signature Page Follows.]

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Second Amendment to Employment Agreement as of the Amendment Effective Date.

 

	 	THE COMPANY:
	 	 
	 	INSPIREMD, INC.
	 	 	 
	 	By:	/s/ Craig Shore
	 	Name:	Craig Shore
	 	Title:	Chief Financial Officer

 

	 	EXECUTIVE:
	 	 
	 	/s/ Alan W. Milinazzo
	 	Alan W. MilinazzoExhibit 10.2

 

AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Amendment
to Employment Agreement (this “Amendment”) is made and entered as of this 5th day of January,
2015, (the “Amendment Effective Date”) by and between InspireMD, Inc., a Delaware corporation (the “Company”),
and James J. Barry, PhD (the “Executive”) for purposes of amending that certain Employment Agreement
dated as of July 14, 2014, by and between the Company and the Executive (the “Agreement”). Terms used
in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms
in the Agreement.

 

WHEREAS, Section
7.5 of the Agreement provides that the parties to the Agreement may amend the Agreement in a writing signed by the parties; and

 

WHEREAS, the
parties hereto desire to amend the Agreement in certain respects.

 

NOW THEREFORE,
pursuant to Section 7.5 of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged,
the Company and the Executive agree as follows:

 

1.      A
new Section 2.5 is hereby added to the Agreement to read in its entirety as follows.

 

2.5          Temporary
Base Salary Redistribution. Notwithstanding the foregoing, the Executive and the Company agree that for a limited period of
time to be mutually agreed to by the parties, the Executive shall receive 50% of his base salary in cash payments, with the remaining
50% to be paid in an equivalent amount of Restricted Stock, payable and granted in equal installments in accordance with the Company’s
normal payroll practices. The Restricted Stock shall vest immediately and be valued as of the trading day on the date the cash
base salary was previously payable. For the avoidance of any doubt, the parties agree that the definition of Base Amount set forth
in Exhibit A hereto, shall refer only to the full amount of the Executive’s base salary prior to any redistribution or reduction
agreed to hereunder.

 

2.      Except as expressly
amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions thereof.

 

3.      In the event
of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

* * * * * * * * * *

[Remainder of Page Intentionally Left
Blank

Signature Page Follows.]

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Amendment to Employment Agreement as of the Amendment Effective Date.

 

	 	THE COMPANY:
	 	 
	 	INSPIREMD, INC.
	 	 
	 	By:	/s/ Alan W. Milinazzo
	 	Name:	Alan W. Milinazzo
	 	Title:	President and Chief Executive Officer
	 	 
	 	EXECUTIVE:
	 	 
	 	/s/ James J. Barry PhD
	 	James J. Barry PhDExhibit 10.3

 

FIRST AMENDMENT TO AMENDED AND RESTATED
EMPLOYMENT AGREEMENT

 

This FIRST
Amendment to AMENDED AND RESTATED Employment Agreement (this “Amendment”) is made and entered
as of this 5th day of January, 2015, (the “Amendment Effective Date”) by and between InspireMD, Inc.,
a Delaware corporation (the “Company”), and Craig Shore (the “Executive”) for
purposes of amending that certain Amended and Restated Employment Agreement dated as of May 5, 2014, by and between the Company
and the Executive (the “Agreement”). Terms used in this Amendment with initial capital letters that are
not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.

 

WHEREAS, Section
7.5 of the Agreement provides that the parties to the Agreement may amend the Agreement in a writing signed by the parties; and

 

WHEREAS, the
parties hereto desire to amend the Agreement in certain respects.

 

NOW THEREFORE,
pursuant to Section 7.5 of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged,
the Company and the Executive agree as follows:

 

1.           Section 2.3 of
the Agreement is hereby amended as of the Amendment Effective Date by deleting said section in its entirety and substituting in
lieu thereof the following new Section 2.3:

 

2.3
Bonus or other Incentive Compensation. During the Term, the Executive shall be eligible to receive annual bonus compensation
in an amount equal to 45% of his then-base salary (the “Annual Bonus”) upon the achievement of reasonable target
objectives and performance goals as may be determined by the Board in consultation with the Executive (the “Goals”).
The Goals shall be based 40% on financial target objectives, 20% on pipeline target objectives (by way of example, for 2014, the
Carotid launch, DES project definition, and Peripheral CE Mark), 20% on clinical target objectives (by way of example, for 2014,
MASTER II enrollment and Carotid CARE study enrollment), and 20% on partnership target objectives (by way of example, for 2014,
the execution of two partnership agreements). Further, the financial target objectives shall be based 75% on the Company’s
revenues and 25% on cash management. The Executive shall be eligible to receive 100% of the Annual Bonus if he achieves 100% of
the Goals. If the Executive achieves less than 100%, then the Executive shall be eligible to receive the corresponding percentage
of the Annual Bonus. By way of example and for illustrative purposes only, if the Executive achieves 85% of the Goals, then he
would be eligible to receive 85% of the Annual Bonus. In the event the Executive’s actual performance exceeds the Goals,
the Board may, in its sole discretion, pay the Executive bonus compensation of more than 100% of the Annual Bonus. In each case,
the Annual Bonus shall be payable in accordance with the Company’s annual bonus plan (the “Bonus Plan”).
Amounts payable under the Bonus Plan shall be determined by the Board and shall be payable following such fiscal year and no later
than two and one-half months after the end of such fiscal year. The Executive’s Annual Bonus
shall be reviewed annually by the Chief Executive Officer for increase in the amount of the percentage of his then-base salary
(but not decrease), as well as the criteria and corresponding percentages for the Goals, as part of the Company’s annual
compensation review. In addition to the Annual
Bonus, the Executive shall be eligible to receive such additional bonus or incentive compensation as the Board may establish from
time to time in its sole discretion. Any bonus or incentive compensation under this Section 2.3, the Bonus Plan or otherwise is
referred to herein as “Incentive Compensation.” Stock-based compensation shall not be considered Incentive Compensation
under the terms of this Agreement unless the parties expressly agree otherwise in writing. The payment of any Incentive Compensation
shall be subject to all federal, state and withholding taxes, social security deductions and other general taxes and any other
withholding obligations required by applicable law. Payment of Incentive Compensation with respect to a particular calendar year
during the Term does not guarantee the award or payment of Incentive Compensation in any subsequent calendar year.

 

    	 

    	 

    

 

2.           Except as expressly
amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions thereof.

 

3.           In the event
of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

* * * * * * * * * *

[Remainder of Page Intentionally Left
Blank

Signature Page Follows.]

 

    	2

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this First Amendment to Amended and Restated Employment Agreement as of the Amendment Effective Date.

 

	 	THE COMPANY:
	 	 
	 	INSPIREMD, INC.
	 	 	 
	 	By:	/s/ Alan W. Milinazzo
	 	Name:	Alan W. Milinazzo
	 	Title:	President and Chief Executive Officer

 

	 	EXECUTIVE:	 
	 	 	 
	 	/s/ Craig Shore	 
	 	Craig Shore

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]